US Stock MarketDetailed Quotes

PTGX Protagonist Therapeutics

Watchlist
  • 41.620
  • +0.970+2.39%
Trading Nov 21 10:25 ET
2.48BMarket Cap15.19P/E (TTM)

Protagonist Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Protagonist Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 43.918M--
--2024/Q4-- / 61.169M--
--2024/Q34.675M / 1.813M--
--2024/Q24.167M / 6.667M--
--2024/Q1254.953M / 120.000M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 43.918M--
--2024/Q4-- / 61.169M--
--2024/Q34.675M / 1.813M--
--2024/Q24.167M / 6.667M--
--2024/Q1254.953M / 120.000M--

Unlock Free Earnings Estimates

Protagonist Therapeutics Earnings Reports

  • Protagonist Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 8 11:36

  • Protagonist Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 7 04:24

  • Protagonist Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 8 04:59

  • Protagonist Therapeutics | 10-K: FY2023 Annual Report

    Feb 28 11:39

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 21, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data